IMIDAZOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

This invention relates to imidazopyridyl compounds of the structural formula: I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprisi...

Full description

Saved in:
Bibliographic Details
Main Authors LONDON, CLARE, WHITEHEAD, BRENT, CAI, JAIQIANG, PARK, MIN, K, TAYLOR, JERRY ANDREW, HOYT, SCOTT, B, ALI, AMJAD, COOKE, ANDREW, RATCLIFFE, PAUL, LO, MICHAEL, XIONG, YUSHENG, CARSWELL, EMMA, BENNETT, D. JONATHAN, MACLEAN, JOHN
Format Patent
LanguageEnglish
French
Published 28.03.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to imidazopyridyl compounds of the structural formula: I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthase. La présente invention concerne des composés imidazopyridyliques de formule développée I, dans laquelle les variables sont telles que définies ici, ou leurs sels pharmaceutiquement acceptables. Les composés de l'invention inhibent de façon sélective l'aldostérone synthase. La présente invention concerne également des compositions pharmaceutiques contenant lesdits composés de formule I ou leurs sels, ainsi que, potentiellement, des méthodes de traitement, d'amélioration ou de prévention d'affections susceptibles d'être traitées grâce à une inhibition de l'aldostérone synthase.
Bibliography:Application Number: WO2012US55694